Clinical Trials Directory

Trials / Completed

CompletedNCT01142960

Effects of Lycium Barbarum Supplements on the Progression of Senile Cataract in Hong Kong Chinese Population

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
238 (actual)
Sponsor
The Hong Kong Polytechnic University · Academic / Other
Sex
All
Age
60 Years – 75 Years
Healthy volunteers
Accepted

Summary

With the rapid growing aging population, age-related eye diseases including cataract are becoming more prevalent. The demand for cataract surgery and post-surgical care posed enormous financial burdens to the government. Lycium barbarum contains lutein and zeaxanthin which can filter the phototoxic blue light and neutralize the reactive oxygen species, thus provide a protective effect against cataract formation. This study aims to determine the effects of Lycium barbarum Supplements on the progression of senile cataract in Hong Kong Chinese elderly.

Detailed description

Please note that a manuscript for this study is being prepared. Detailed description will be provided after we come up with the final draft.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTStarch1350mg/day
DIETARY_SUPPLEMENTLycium Barbarum1350mg/day

Timeline

Start date
2009-11-01
Primary completion
2012-04-01
Completion
2012-06-01
First posted
2010-06-14
Last updated
2016-05-12

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT01142960. Inclusion in this directory is not an endorsement.

Effects of Lycium Barbarum Supplements on the Progression of Senile Cataract in Hong Kong Chinese Population (NCT01142960) · Clinical Trials Directory